Skip to content
  • Investors
  • NASDAQ: HSDT
  • Newsletter Sign Up
  • Careers
  • Investors
  • NASDAQ: HSDT
  • Newsletter Sign Up
  • Careers
Helius Medical Technologies Logo
  • About Helius
    • Overview
    • Management Team
    • Board of Directors
  • Our Technology
  • PoNS
  • Research
  • News
  • Contact
  • About Helius
    • Overview
    • Management Team
    • Board of Directors
  • Our Technology
  • PoNS
  • Research
  • News
  • Contact
  • Home
  • About Helius
    • Overview
    • The Management Team
    • Board of Directors
  • Our Technology
  • PoNS
  • Research
  • News
  • Contact
  • Investors
  • PoNS Therapy (US & CA)
  • Newsletter SignUp
  • Careers
Explore PoNS Therapy

(available only in the US and Canada)

Author: Mark

Neuromodulation: Where to Invest Next?

For an investor, neuromodulation is a double-edged sword. Although it is one of the fastest growing

Positive Results from PoNS Trial

Helius Medical Technologies Inc., a medical technology company focused on neurological

Announcing Online Training for PoNS Therapy

We are pleased to introduce our online PoNS Therapy training curriculum. In the past, therapists treating

BNN Interview at the Toronto Stock Exchange

Fabrice Taylor, publisher of the President’s Club Investment Letter, discusses Helius Medical

© 2025 Helius Medical Technologies, Inc.

Call Us +1 877-564-0008 or

Send us a message 

  • Privacy Policy
  • Regulatory Disclaimer
  • Forward-Looking Statements
  • Terms of Use
  • Site Map
  • Privacy Policy
  • Regulatory Disclaimer
  • Forward-Looking Statements
  • Terms of Use
  • Site Map